Bio-Techne Corporation

NASDAQ:TECH

Biotechnology

Healthcare
$72.75 -1.84%

-$1.03 today

Market cap
$11.43B
Beta
1.36
P/E (TTM)
78.3
EPS (TTM)
$0.70
Dividend yield
0.58%
52W Low $43.20High $72.16

Volume 2.63M

Average 2.66M

TECH Other Income / Expenses

Net non-operating gains and losses, such as investment results, currency effects, and one-off items.

Bio-Techne CorporationNASDAQ: TECH

Other Income / Expenses · Q1 FY2027 · quarter ended Sep 2026

Other income / expenses turns negative

Q1 FY2027 other income / expenses was -$1.91M, compared with $333K a year earlier. Trailing-twelve-month other income / expenses was -$13.45M.

Context

  • Other income / expenses amounted to 0.9% of revenue in FY2026, up 0.6 pp from a year earlier.
  • Other income / expenses increased in 1 of the last 3 fiscal years.

What to watch

Whether quarterly other income / expenses holds near -$1.91M or moves back toward the trailing-twelve-month quarterly average of -$3.36M.

Sources:Income StatementText generated from reported figures; not investment advice.

Latest quarterSep 2026
-$1.91M+46.9% QoQ
Last fiscal yearJun 2026
-$11.21M-195.6% YoY
LTMSep 2026
-$13.45M-269.3% YoY
Other Income / Expenses past and forecast growth by horizon
Horizon Past Forecast Difference
Quarter-673.6%——
1 year-195.6%——
3-year CAGR———
5-year CAGR——
10-year CAGR——

Other Income / Expenses history

USD · from the income statement

Latest · FY2026
(11.21M) USD
Year-over-year change
-195.6%

Other Income / Expenses vs competitors

How TECH compares with its peers on the latest reported figures

  • TECH's LTM Sep 2026 other income / expenses of -$13.45M is the 6th highest of the 11 companies compared; the peer median is -$34.04M.
  • Its year-over-year change of -269.3% is the 9th highest of 10, against a peer median of -49.1%.
  • Other income / expenses amounts to 1.1% of revenue for TECH, versus a peer median of 3.1%.
TECH Competitors Peer median
Other Income / Expenses for TECH and competitors
Company Period LTM YoY 3-year CAGR% of revenue
BIOBio-Rad Laboratories, Inc.LTM Jun 2026$115.4M -49.1%—4.5%
AAgilent Technologies, Inc.LTM Jul 2026$19M +138.0%—0.3%
TXG10x Genomics, Inc.LTM Sep 2026$7.04M -61.3%+128.2%1.1%
SEERSeer, Inc.LTM Mar 2026$4.27M -57.4%-0.2%28.4%
ALMRAlamar Biosciences, Inc.FY2025$2.18M ——2.9%
TECHBio-Techne CorporationLTM Sep 2026-$13.45M -269.3%—1.1%
QGENQiagen N.V.LTM Jun 2026-$70.26M -447.3%—3.3%
RVTYRevvity, Inc.LTM Jul 2026-$98.08M -19.7%—3.4%
BRKRBruker CorporationLTM Jun 2026-$154.6M -224.8%—4.4%
DHRDanaher CorporationLTM Sep 2026-$400M +66.4%—1.6%
TMOThermo Fisher Scientific Inc.LTM Sep 2026-$646M +34.1%—1.4%
Peer median (excluding TECH) -$34.04M-49.1%+64.0%3.1%

Competitors are the stored peer set for TECH. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Income Statement

USD
Metric
FY2022
Jun 2022
FY2023
Jun 2023
FY2024
Jun 2024
FY2025
Jun 2025
FY2026
Jun 2026
Revenue1.11B1.14B1.16B1.22B1.22B
Cost of Revenue349.1M366.89M389.34M429.36M415.97M
Gross Profit756.5M769.82M769.73M790.27M799.07M
Gross Margin68.4%67.7%66.4%64.8%65.8%
Research & Development87.14M92.49M96.66M99.5M94.77M
Selling, General & Admin339M352.44M393.32M415.1M452.42M
Operating Expenses459.91M470.87M563.04M688.02M547.18M
Depreciation & Amortization101.07M107.24M111.71M109.9M97.36M
EBITDA413.76M457.11M313.14M216.88M343.44M
EBITDA Margin37.4%40.2%27.0%17.8%28.3%
Operating Income296.59M298.94M206.69M102.26M251.89M
Operating Margin26.8%26.3%17.8%8.4%20.7%
Interest Income794K3.41M3.32M3.89M0
Interest Expense11.31M11.22M15.74M8.51M5.41M
Other Income / Expenses4.8M39.72M(21M)(3.79M)(11.21M)
Income Before Tax301.39M338.66M185.69M98.46M240.68M
Pre-Tax Margin27.3%29.8%16.0%8.1%19.8%
Income Tax Expense38.29M53.22M17.58M25.06M58.82M
Net Income272.05M285.26M168.11M73.4M181.86M
Net Margin24.6%25.1%14.5%6.0%15.0%
EPS (Basic)1.731.811.070.471.17
EPS (Diluted)1.661.761.050.461.16
Weighted Avg Shares156.88M157.18M157.71M157.52M155.96M
Weighted Avg Shares (Diluted)164.12M161.86M160.77M159.72M157.01M

Bio-Techne Corporation

NASDAQ:TECH

Intrinsic Alpha fair value

Locked

Current Price

$72.75

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.